Published in J Clin Invest on December 15, 1996
Regulation of peripheral inflammation by spinal p38 MAP kinase in rats. PLoS Med (2006) 1.57
Peripheral and central sensitization in remote spinal cord regions contribute to central neuropathic pain after spinal cord injury. Pain (2009) 1.48
Acetylcholine regulation of synoviocyte cytokine expression by the alpha7 nicotinic receptor. Arthritis Rheum (2008) 1.34
Suppression of inflammation by low-dose methotrexate is mediated by adenosine A2A receptor but not A3 receptor activation in thioglycollate-induced peritonitis. Arthritis Res Ther (2006) 1.09
Adenosine receptor agonists for promotion of dermal wound healing. Biochem Pharmacol (2008) 1.06
Diabetic retinopathy: Role of inflammation and potential therapies for anti-inflammation. World J Diabetes (2010) 0.88
A(₂A) adenosine receptor (A(₂A)AR) as a therapeutic target in diabetic retinopathy. Am J Pathol (2011) 0.86
Adenosine in fibrosis. Mod Rheumatol (2009) 0.86
Role of adenosine in diabetic retinopathy. J Ocul Biol Dis Infor (2012) 0.79
Regulation of peripheral inflammation by the central nervous system. Curr Rheumatol Rep (2010) 0.77
Cannabidiol As a Putative Novel Therapy for Diabetic Retinopathy: A Postulated Mechanism of Action as an Entry Point for Biomarker-Guided Clinical Development. Curr Pharmacogenomics Person Med (2009) 0.76
Restraint stress fails to modulate cutaneous hypersensitivity responses in mice lacking the adenosine A1 receptor. Purinergic Signal (2011) 0.75
Spinal GABA-B receptor modulates neutrophil recruitment to the knee joint in zymosan-induced arthritis. Naunyn Schmiedebergs Arch Pharmacol (2016) 0.75
Antinociceptive Activity of Borreria verticillata: In vivo and In silico Studies. Front Pharmacol (2017) 0.75
Chronic catheterization of the spinal subarachnoid space. Physiol Behav (1976) 6.16
[3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain. J Pharmacol Exp Ther (1989) 4.18
Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes. Mol Pharmacol (1986) 4.15
Cardiovascular purinoceptors. Physiol Rev (1990) 3.70
The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia. Br J Pharmacol (1992) 3.21
Excitatory amino acid receptors in the vertebrate central nervous system. Pharmacol Rev (1989) 2.82
How does adenosine inhibit transmitter release? Trends Pharmacol Sci (1988) 2.20
Pharmacology of the spinal action of ketorolac, morphine, ST-91, U50488H, and L-PIA on the formalin test and an isobolographic analysis of the NSAID interaction. Anesthesiology (1993) 1.86
Neutrophil adherence to endothelium is enhanced via adenosine A1 receptors and inhibited via adenosine A2 receptors. J Immunol (1992) 1.84
Metabotropic glutamate receptors in brain function and pathology. Trends Pharmacol Sci (1993) 1.65
Release of substance P from the cat spinal cord. J Physiol (1987) 1.52
Adenosine decreases aspartate and glutamate release from rat hippocampal slices. Eur J Pharmacol (1984) 1.19
Analogs of caffeine: antagonists with selectivity for A2 adenosine receptors. Life Sci (1986) 1.17
Modulation of carrageenan-induced hind paw edema by substance P. Inflammation (1994) 1.10
N-methyl-D-aspartate (NMDA) and non-NMDA receptor antagonists block the hyperexcitability of dorsal horn neurons during development of acute arthritis in rat's knee joint. J Neurophysiol (1993) 1.07
The antiinflammatory effects of an adenosine kinase inhibitor are mediated by adenosine. Arthritis Rheum (1995) 1.06
Centrally administered non-NMDA but not NMDA receptor antagonists block peripheral knee joint inflammation. Pain (1993) 1.06
Temporal analysis of increases in c-fos, preprodynorphin and preproenkephalin mRNAs in rat spinal cord. Brain Res Mol Brain Res (1989) 1.04
An experimental arthritis in rats: dorsal horn aspartate and glutamate increases. Neurosci Lett (1992) 1.04
The role of glutamate and GABA receptors in the generation of dorsal root reflexes by acute arthritis in the anaesthetized rat. J Physiol (1995) 1.04
Release of immunoreactive substance P in the spinal cord during development of acute arthritis in the knee joint of the cat: a study with antibody microprobes. Brain Res (1990) 1.03
Do dorsal root reflexes augment peripheral inflammation? Neuroreport (1994) 1.02
Leukocyte adherence in rat mesenteric venules: effects of adenosine and methotrexate. Gastroenterology (1993) 0.99
An adenosine agonist inhibits and a cyclic AMP analogue enhances the release of glutamate but not GABA from slices of rat dentate gyrus. Neurosci Lett (1983) 0.99
The antiinflammatory effects of adenosine receptor agonists on the carrageenan-induced pleural inflammatory response in rats. J Immunol (1990) 0.98
Changes in extracellular potassium concentration in cat spinal cord in response to innocuous and noxious stimulation of legs with healthy and inflamed knee joints. Exp Brain Res (1990) 0.98
The intrathecal administration of excitatory amino acid receptor antagonists selectively attenuated carrageenan-induced behavioral hyperalgesia in rats. Eur J Pharmacol (1992) 0.97
Polymorphonuclear leukocyte accumulation in inflammatory dermal sites as measured by 51Cr-labeled cells and myeloperoxidase. Inflammation (1983) 0.94
Adenosine inhibits ischemia-reperfusion-induced leukocyte adherence and extravasation. Am J Physiol (1989) 0.93
Anti-inflammatory effects of an adenosine kinase inhibitor. Decreased neutrophil accumulation and vascular leakage. J Immunol (1995) 0.91
The Effects of NMDA Antagonists on Neuronal Activity in Cat Spinal Cord Evoked by Acute Inflammation in the Knee Joint. Eur J Neurosci (1991) 0.89
Release and spread of immunoreactive neurokinin A in the cat spinal cord in a model of acute arthritis. Brain Res (1990) 0.83
A pharmacological and histological examination of the microcirculation of the rat subcutaneous air-pouch: microcirculation of the rat air-pouch. Pathology (1987) 0.80
Cerebral protection by adenosine. Acta Neurochir Suppl (Wien) (1993) 0.79
Reduction of postischemic leukocyte-endothelium interaction by adenosine via A2 receptor. Naunyn Schmiedebergs Arch Pharmacol (1992) 0.79
NF-kappaB: a key role in inflammatory diseases. J Clin Invest (2001) 9.66
c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J Clin Invest (2001) 3.86
Dominant-negative p53 mutations in rheumatoid arthritis. Arthritis Rheum (1999) 2.18
Cytokines in chronic inflammatory arthritis. II. Granulocyte-macrophage colony-stimulating factor in rheumatoid synovial effusions. J Clin Invest (1989) 2.18
AP-1 and NF-kappaB regulation in rheumatoid arthritis and murine collagen-induced arthritis. Autoimmunity (1998) 2.09
Alpha 4/beta 1 integrin (VLA-4) ligands in arthritis. Vascular cell adhesion molecule-1 expression in synovium and on fibroblast-like synoviocytes. J Immunol (1992) 2.08
Peripheral blood and synovial fluid monocyte activation in inflammatory arthritis. II. Low levels of synovial fluid and synovial tissue interferon suggest that gamma-interferon is not the primary macrophage activating factor. Arthritis Rheum (1987) 2.04
Rheumatoid arthritis and p53: how oxidative stress might alter the course of inflammatory diseases. Immunol Today (2000) 2.03
Synergistic benefit in inflammatory arthritis by targeting I kappaB kinase epsilon and interferon beta. Ann Rheum Dis (2008) 1.82
Eosinophils express interleukin 5 and granulocyte macrophage-colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics. J Clin Invest (1992) 1.81
Expression and function of wingless and frizzled homologs in rheumatoid arthritis. Proc Natl Acad Sci U S A (2000) 1.81
Inhibition of TNF-alpha expression by adenosine: role of A3 adenosine receptors. J Immunol (1996) 1.75
Assessment of rituximab's immunomodulatory synovial effects (ARISE trial). 1: clinical and synovial biomarker results. Ann Rheum Dis (2007) 1.65
Gene encoding a new RING-B-box-Coiled-coil protein is mutated in mulibrey nanism. Nat Genet (2000) 1.63
Pannus and pannocytes. Alternative models of joint destruction in rheumatoid arthritis. Arthritis Rheum (1994) 1.61
Management and outcomes of pregnancies complicated by human B19 parvovirus infection: a prospective study. Am J Obstet Gynecol (1990) 1.58
Jun N-terminal kinase in rheumatoid arthritis. J Pharmacol Exp Ther (1999) 1.52
Inhibitor of nuclear factor kappaB kinase beta is a key regulator of synovial inflammation. Arthritis Rheum (2001) 1.49
"Go upstream, young man": lessons learned from the p38 saga. Ann Rheum Dis (2010) 1.48
The effect of a T cell-specific NF-kappa B inhibitor on in vitro cytokine production and collagen-induced arthritis. J Immunol (2000) 1.43
Adenosine kinase inhibitor GP515 improves experimental colitis in mice. J Pharmacol Exp Ther (2001) 1.40
Mode of action of abatacept in rheumatoid arthritis patients having failed tumour necrosis factor blockade: a histological, gene expression and dynamic magnetic resonance imaging pilot study. Ann Rheum Dis (2008) 1.40
Analysis of the p53 tumor suppressor gene in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum (1999) 1.39
NF-kappa B regulation by I kappa B kinase in primary fibroblast-like synoviocytes. J Immunol (1999) 1.36
p53 overexpression in synovial tissue from patients with early and longstanding rheumatoid arthritis compared with patients with reactive arthritis and osteoarthritis. Arthritis Rheum (1999) 1.35
Expression and functional significance of alternatively spliced CS1 fibronectin in rheumatoid arthritis microvasculature. J Clin Invest (1994) 1.34
Fibroblast-like synoviocytes support B-cell pseudoemperipolesis via a stromal cell-derived factor-1- and CD106 (VCAM-1)-dependent mechanism. J Clin Invest (2001) 1.30
Pathogenesis of rheumatoid arthritis: the role of synoviocytes. Rheum Dis Clin North Am (2001) 1.30
Invasiveness of synovial fibroblasts is regulated by p53 in the SCID mouse in vivo model of cartilage invasion. Arthritis Rheum (2001) 1.26
Regulation of synoviocyte proliferation, apoptosis, and invasion by the p53 tumor suppressor gene. Am J Pathol (1998) 1.26
Empirical advantages of adeno associated viral vectors in vivo gene therapy for arthritis. J Rheumatol (2000) 1.23
Mouth and genital ulcers with inflamed cartilage: MAGIC syndrome. Five patients with features of relapsing polychondritis and Behçet's disease. Am J Med (1985) 1.22
Suppression of murine collagen-induced arthritis by targeted apoptosis of synovial neovasculature. Arthritis Res (2001) 1.16
Endobronchial allergen challenge in asthma. Demonstration of cellular source of granulocyte macrophage colony-stimulating factor by in situ hybridization. J Clin Invest (1991) 1.16
Peripheral blood and synovial fluid monocyte activation in inflammatory arthritis. I. A cytofluorographic study of monocyte differentiation antigens and class II antigens and their regulation by gamma-interferon. Arthritis Rheum (1987) 1.14
Pannocytes: distinctive cells found in rheumatoid arthritis articular cartilage erosions. Am J Pathol (1997) 1.13
Pregnancy outcome following first-trimester varicella infection. Obstet Gynecol (1992) 1.13
Down regulation of human monocyte differentiation antigens by interferon gamma. Cell Immunol (1987) 1.13
Mitogen activated protein kinase inhibitors: where are we now and where are we going? Ann Rheum Dis (2006) 1.13
Transforming growth factor-beta 1 selectively inhibits IL-3-dependent mast cell proliferation without affecting mast cell function or differentiation. J Immunol (1989) 1.05
Reversible cold-induced abnormalities in myocardial perfusion and function in systemic sclerosis. Ann Intern Med (1986) 1.05
Signal transduction networks in rheumatoid arthritis. Ann Rheum Dis (2003) 1.04
Prostaglandins increase proMMP-1 and proMMP-3 secretion by human ciliary smooth muscle cells. Curr Eye Res (1996) 1.02
Enhanced gene transfer to arthritic joints using adeno-associated virus type 5: implications for intra-articular gene therapy. Ann Rheum Dis (2005) 1.01
Modulation of fibroblast-mediated cartilage degradation by articular chondrocytes in rheumatoid arthritis. Arthritis Rheum (2000) 0.99
Alternatively spliced CS-1 fibronectin isoform and its receptor VLA-4 in rheumatoid arthritis synovium. J Rheumatol (1997) 0.99
Inhibition of synoviocyte collagenase gene expression by adenosine receptor stimulation. Arthritis Rheum (1996) 0.98
Collagen induced arthritis: reversal by mercaptoethylguanidine, a novel antiinflammatory agent with a combined mechanism of action. J Rheumatol (1998) 0.95
Apoptosis and p53 expression in rat adjuvant arthritis. Arthritis Res (2000) 0.94
Direct synovial gene transfer with retroviral vectors in rat adjuvant arthritis. J Rheumatol (1998) 0.94
p53 in rheumatoid arthritis synovial fibroblasts at sites of invasion. Ann Rheum Dis (2003) 0.93
DNA mismatch repair enzyme expression in synovial tissue. Ann Rheum Dis (2004) 0.92
Anticytokine therapy in rheumatoid arthritis. N Engl J Med (1997) 0.92
Anti-inflammatory effects of ABT-702, a novel non-nucleoside adenosine kinase inhibitor, in rat adjuvant arthritis. J Pharmacol Exp Ther (2001) 0.91
Anti-inflammatory effects of an adenosine kinase inhibitor. Decreased neutrophil accumulation and vascular leakage. J Immunol (1995) 0.91
Acid-sensing ion channel 3 expressed in type B synoviocytes and chondrocytes modulates hyaluronan expression and release. Ann Rheum Dis (2009) 0.90
Dual activation of adenosine A1 and A3 receptors mediates preconditioning of isolated cardiac myocytes. Eur J Pharmacol (1997) 0.90
cDNA cloning and sequence analysis of the human A3 adenosine receptor. Biochim Biophys Acta (1993) 0.90
Expression and regulation of inducible IkappaB kinase (IKK-i) in human fibroblast-like synoviocytes. Cell Immunol (2001) 0.89
Protection of mice from endotoxic death by 2-methylthio-ATP. Proc Natl Acad Sci U S A (1994) 0.86
Mutual antagonism between interferon-gamma and tumor necrosis factor-alpha on fibroblast-like synoviocytes: paradoxical induction of IFN-gamma and TNF-alpha receptor expression. J Clin Immunol (1993) 0.86
Regulation of CS1 fibronectin expression and function by IL-1 in endothelial cells. Cell Immunol (2000) 0.85
Reactive arthritis. Annu Rev Med (1987) 0.85
MKK3, an upstream activator of p38, contributes to formalin phase 2 and late allodynia in mice. Neuroscience (2009) 0.85
Early synovitis--synoviocytes and mononuclear cells. Semin Arthritis Rheum (1994) 0.85
Reproductive fitness in maternal homocystinuria due to cystathionine beta-synthase deficiency. J Inherit Metab Dis (2002) 0.84
Cytokines in chronic inflammatory synovitis. Scand J Rheumatol Suppl (1988) 0.83
Adenosine activates A2 receptors to inhibit neutrophil adhesion and injury to isolated cardiac myocytes. J Immunol (1995) 0.83
The role of T cells in rheumatoid arthritis. Ann Rheum Dis (1993) 0.82
Intra-articular IL-4 gene therapy in arthritis: anti-inflammatory effect and enhanced th2activity. Gene Ther (1999) 0.82
DNA diagnosis and management of Hermansky-Pudlak syndrome in pregnancy. Am J Perinatol (2001) 0.82
Maternal separation in early life impairs tumor immunity in adulthood in the F344 rat. Stress (2011) 0.82
Occupational risk factors for infection with parvovirus B19 among pregnant women. J Infect Dis (1991) 0.81
VIP: a very important protein in arthritis. Nat Med (2001) 0.81
Neutrophils increase volume during migration in vivo and in vitro. Am J Respir Cell Mol Biol (1994) 0.81
Suppression of TNF-alpha production in human mononuclear cells by an adenosine kinase inhibitor. J Leukoc Biol (2000) 0.81
Early cirrhosis in survivors with Jeune thoracic dystrophy. J Pediatr (1992) 0.80
Posttranscriptional regulation of collagenase-1 gene expression in synoviocytes by adenosine receptor stimulation. Arthritis Rheum (1997) 0.79
Cytokine-induced differentiation of cultured nonadherent macrophages. Cell Immunol (1992) 0.79
Validated gene expression biomarker analysis for biopsy-based clinical trials in ulcerative colitis. Aliment Pharmacol Ther (2014) 0.79
Cytokines in chronic inflammatory arthritis. III. Rheumatoid arthritis monocytes are not unusually sensitive to gamma-interferon, but have defective gamma-interferon-mediated HLA-DQ and HLA-DR induction. Arthritis Rheum (1989) 0.79
Age-dependent neutrophil and blood flow responsiveness in acute pulmonary inflammation in rabbits. Am J Physiol (1997) 0.78
A study on the Wassermann and TPI antibodies in relation to histopathological findings in T. pallidum infected animals and man. Acta Pathol Microbiol Scand (1968) 0.78
cDNA cloning and characterization of A3i, an alternatively spliced rat A3 adenosine receptor variant. FEBS Lett (1996) 0.78
Development of a phase III trial of hematopoietic stem cell transplantation for systemic lupus erythematosus. Bone Marrow Transplant (2003) 0.77
Effect of tenidap on metalloproteinase gene expression in rheumatoid arthritis: a synovial biopsy study. J Clin Rheumatol (1997) 0.76
Adenosine kinase inhibitor GP515 attenuates hepatic leukocyte adhesion after hemorrhagic hypotension. Am J Physiol (1997) 0.75
Carbohydrate- and CD18-dependent neutrophil adhesion to cardiac myocytes: effects of adenosine. Cardiovasc Res (1996) 0.75
Endogenous adenosine formation can regulate human neutrophil function. Adv Exp Med Biol (1994) 0.75
Deoxy-ATP accumulation in adenosine deaminase-inhibited human B and T lymphocytes. Adv Exp Med Biol (1986) 0.75
The effects of gamma-interferon on human peripheral blood monocyte/macrophage-mediated bone particle degradation. Bone Miner (1990) 0.75
Relapsing polychondritis and pregnancy: normal fetal outcome despite maternal flares. J Clin Rheumatol (1996) 0.75
[Intracellular signaling transduction pathways. Potential targets in the treatment of rheumatic diseases]. Z Rheumatol (2012) 0.75